Skip to content
NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE CAP

Progyny, Inc. PGNY

9 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.3B
▲ 10.4% YoY
$58.5M
▲ 7.7% YoY
$191.8M
▲ 10.4% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Progyny, Inc. contracts with employers to provide women's health and family building benefits to their employees and covered dependents. It currently has contracts to provide coverage to approximately 7.2 million employees and their covered dependents, referred to in the industry as covered lives. It has grown its client base to more than 590 employers, each with at least 1,000 covered lives. As of December 31, 2025, it had 856 employees, of which 835 were full-time. It launched its fertility benefits solution in 2016 with five employer clients and has since expanded its platform to include solutions in pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing. Progyny, Inc. was incorporated in Delaware in 2008 under the name Auxogen Bioscience, Inc., changed its name to Auxogen, Inc. in 2010, and changed its name to Progyny, Inc. in 2015.

Written from the business description in Progyny, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 1.3B
Revenue, FY2025 · full 9-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.3 · Net income 0.1
0.5B1.0B
2017202020232025
Compound annual growth
+17.9%
+30.2%
+24.5%
+4.7%
+29.4%
+6.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +30.2% a year over the five years to FY2025 — but profit grew slower: net income at +4.7%, earnings per share at +6.7%.

The share count fell from 0.09B to 0.08B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

5 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 6.6% · Net 4.5%
5%10%-10%-20%
201720212025
ROE
FY2025 · ROE 12.5%
10%20%30%
201720212025
Three returns, three denominators.

Each USD of equity produced 12 cents of profit this year.

Cash & shareholders

USD 81.6M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 191.8
100M200M
201720212025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 81.6
150M300M
201820192022202320242025

USD 81.6M in buybacks — 139% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 742.4M
EquityUSD 516.0M
CashUSD 112.2M
Current ratio2.73×

Equity funds 70% of total assets.

The 9-year record

9 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
PGNY, 9-year financial record
Metric 202520242023202220212020201920182017
Revenue $B1.31.21.10.80.50.30.20.10.0
Operating income $B0.10.10.10.00.00.00.0−0.0−0.0
EBITDA $B0.10.10.10.00.00.00.0−0.0−0.0
Income tax $B0.00.00.0−0.0−0.0−0.00.0−0.0−0.0
Net income $B0.10.10.10.00.10.0−0.00.0−0.0
Free cash flow $B0.20.20.20.10.00.0−0.00.0−0.0
EPS, diluted $0.650.570.620.300.660.47−0.410.04−2.37
Dividend / sh $◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————
ROE %12.511.113.39.731.433.0———
Shares out B0.080.090.100.090.090.090.010.01◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 1 failure in 43 reconciliationsAUDITED

Reconciled in 8 of the 9 fiscal years we could check. 22 checks were skipped: the balance sheet is not tagged before 2018. 10 checks were skipped: EPS is not tagged before 2017. 10 checks were skipped: revenue is not tagged before 2017.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivityServices-Misc Health & Allied Services, NEC
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2017

Share this section

Download image